BN Business News
Add your company to Business Communicator →

Business · 10/15/2026

XtalPi Nominates Its First siRNA Preclinical Candidate for IgA Nephropathy Nine Months After Program Initiation

XtalPi has nominated its first siRNA preclinical candidate for IgA Nephropathy, nine months after program initiation, with preclinical data demonstrating subnanomolar silencing potency.

Original source language: PR NewswireOpen original release →